Corbus Pharmaceuticals (CRBP) Competitors $14.83 +1.82 (+13.99%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$14.89 +0.06 (+0.43%) As of 10/3/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRBP vs. OLMA, ARCT, NBTX, ARVN, IVA, ESPR, ERAS, KOD, CYRX, and ETONShould you be buying Corbus Pharmaceuticals stock or one of its competitors? The main competitors of Corbus Pharmaceuticals include Olema Pharmaceuticals (OLMA), Arcturus Therapeutics (ARCT), Nanobiotix (NBTX), Arvinas (ARVN), Inventiva (IVA), Esperion Therapeutics (ESPR), Erasca (ERAS), Kodiak Sciences (KOD), CryoPort (CYRX), and Eton Pharmaceuticals (ETON). These companies are all part of the "pharmaceutical products" industry. Corbus Pharmaceuticals vs. Its Competitors Olema Pharmaceuticals Arcturus Therapeutics Nanobiotix Arvinas Inventiva Esperion Therapeutics Erasca Kodiak Sciences CryoPort Eton Pharmaceuticals Olema Pharmaceuticals (NASDAQ:OLMA) and Corbus Pharmaceuticals (NASDAQ:CRBP) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, valuation, earnings, dividends and media sentiment. Is OLMA or CRBP more profitable? Olema Pharmaceuticals' return on equity of -42.58% beat Corbus Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Olema PharmaceuticalsN/A -42.58% -38.65% Corbus Pharmaceuticals N/A -43.65%-39.62% Does the media favor OLMA or CRBP? In the previous week, Olema Pharmaceuticals had 3 more articles in the media than Corbus Pharmaceuticals. MarketBeat recorded 4 mentions for Olema Pharmaceuticals and 1 mentions for Corbus Pharmaceuticals. Olema Pharmaceuticals' average media sentiment score of 0.93 beat Corbus Pharmaceuticals' score of 0.75 indicating that Olema Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Olema Pharmaceuticals 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Corbus Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, OLMA or CRBP? Olema Pharmaceuticals is trading at a lower price-to-earnings ratio than Corbus Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOlema PharmaceuticalsN/AN/A-$129.47M-$1.98-5.61Corbus PharmaceuticalsN/AN/A-$40.21M-$4.76-3.12 Do analysts recommend OLMA or CRBP? Olema Pharmaceuticals presently has a consensus price target of $24.00, suggesting a potential upside of 116.22%. Corbus Pharmaceuticals has a consensus price target of $45.43, suggesting a potential upside of 206.33%. Given Corbus Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Corbus Pharmaceuticals is more favorable than Olema Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Olema Pharmaceuticals 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.57Corbus Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.90 Which has more risk and volatility, OLMA or CRBP? Olema Pharmaceuticals has a beta of 2.08, suggesting that its share price is 108% more volatile than the S&P 500. Comparatively, Corbus Pharmaceuticals has a beta of 2.84, suggesting that its share price is 184% more volatile than the S&P 500. Do institutionals and insiders have more ownership in OLMA or CRBP? 91.8% of Olema Pharmaceuticals shares are held by institutional investors. Comparatively, 64.6% of Corbus Pharmaceuticals shares are held by institutional investors. 16.4% of Olema Pharmaceuticals shares are held by insiders. Comparatively, 3.6% of Corbus Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryOlema Pharmaceuticals and Corbus Pharmaceuticals tied by winning 7 of the 14 factors compared between the two stocks. Get Corbus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRBP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRBP vs. The Competition Export to ExcelMetricCorbus PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$181.74M$2.63B$6.14B$10.58BDividend YieldN/A56.38%5.67%4.69%P/E Ratio-3.1224.2278.0526.70Price / SalesN/A726.66605.13131.81Price / CashN/A172.1237.9061.31Price / Book1.275.3412.556.55Net Income-$40.21M$32.92M$3.31B$277.50M7 Day Performance22.46%3.90%4.28%2.42%1 Month Performance50.41%8.79%6.90%8.63%1 Year Performance-22.80%-3.79%70.54%31.60% Corbus Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRBPCorbus Pharmaceuticals4.1453 of 5 stars$14.83+14.0%$45.43+206.3%-22.8%$181.74MN/A-3.1240OLMAOlema Pharmaceuticals3.1724 of 5 stars$8.35+2.2%$24.00+187.5%-4.3%$560.74MN/A-4.2270News CoverageARCTArcturus Therapeutics2.6033 of 5 stars$21.03+2.8%$50.57+140.5%-5.5%$555.58M$152.31M-9.43180NBTXNanobiotix1.2641 of 5 stars$12.86+11.1%$11.00-14.5%+295.2%$554.70M$39.18M0.00100News CoverageShort Interest ↓Analyst RevisionARVNArvinas3.1015 of 5 stars$7.53+0.1%$17.13+127.5%-61.5%$552.10M$263.40M-7.46420IVAInventiva3.3357 of 5 stars$6.02+6.5%$14.83+146.4%+248.9%$540.49M$9.95M0.00100Analyst ForecastESPREsperion Therapeutics3.8505 of 5 stars$2.51-5.6%$7.00+178.9%+52.8%$536.32M$332.31M-5.12200News CoverageGap UpERASErasca2.5004 of 5 stars$1.78-3.3%$3.71+108.7%-4.7%$521.95MN/A-3.96120News CoverageKODKodiak Sciences2.9994 of 5 stars$15.01+57.5%$10.50-30.0%+466.2%$503.39MN/A-3.9590Gap UpHigh Trading VolumeCYRXCryoPort3.8177 of 5 stars$10.13+1.6%$12.56+23.9%+22.7%$499.17M$228.38M7.621,186ETONEton Pharmaceuticals2.2205 of 5 stars$18.37+0.2%$29.67+61.5%+184.7%$491.83M$39.01M-114.8120Positive News Related Companies and Tools Related Companies OLMA Alternatives ARCT Alternatives NBTX Alternatives ARVN Alternatives IVA Alternatives ESPR Alternatives ERAS Alternatives KOD Alternatives CYRX Alternatives ETON Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRBP) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corbus Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Corbus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRBP Stock Alerts